Selkirk Pharma Announces New APS Qualified Facility with Advanced Fill/Finish Capacity in Spokane, WA
View the full release here: https://www.businesswire.com/news/home/20240215019715/en/
- View the full release here: https://www.businesswire.com/news/home/20240215019715/en/
Selkirk Pharma's state-of-the-art APS qualified facility, purpose-built for contract manufacturing with advanced fill/finish capabilities and unidirectional flow technology. - The new US based facility will be crucial in alleviating growing demands and capacity constraints within the fill/finish industry.
- “The completion of our facility's aseptic process simulation qualification is a milestone achievement for the Selkirk team,” said John Bertagnolli, Vice President of Operations at Selkirk Pharma.
- To learn more about Selkirk Pharma’s available capacity, capabilities, and commitment to quality, please contact Selkirk Pharma via www.selkirkpharma.com or email [email protected] .